Posts tagged Monitoring
Echo awarded method patent for Symphony transdermal continuous glucose monitoring system
Echo Therapeutics, Inc. (OTCBB: ECTE), a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it received a notice of allowance for U.S. Patent Application No.11/275,038, "System and Method for Continuous Non-Invasive Glucose Monitoring," for the Symphony tCGM System. More >
Medtronic introduces Enlite Sensor for continuous glucose monitoring
Medtronic, Inc. (NYSE: MDT) announces the launch of Enlite™ Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring (CGM), in more than 35 countries outside of the United States. CGM has been shown in multiple landmark clinical studies to help diabetes patients achieve better glucose control without increasing hypoglycemia (low blood sugar), a dangerous and potentially life-threatening complication of diabetes. The More >
Study finds ‘white coat’ hypertension in patients during 24-hour ambulatory monitoring
A third of patients thought to have resistant hypertension had "white coat" hypertension during 24-hour ambulatory monitoring, in a large study reported in Hypertension: Journal of the American Heart Association.
In ambulatory blood pressure monitoring, the patient’s blood pressure is checked at regular intervals under normal living and working conditions.
Resistant hypertension occurs when a patient’s blood pressure remains More >
Ambulatory monitoring reveals many patients have ‘white coat’ hypertension
ScienceDaily (Mar. 28, 2011) A third of patients thought to have resistant hypertension had "white coat" hypertension during 24-hour ambulatory monitoring, in a large study reported in Hypertension: Journal of the American Heart Association.
In ambulatory blood pressure monitoring, the patient’s blood pressure is checked at regular intervals under normal living and working conditions.
Resistant hypertension occurs when More >
Monitoring by Nurses Aids Chronic Illness Care
Action Points Explain that patients with chronic illnesses and coexisting depression had significantly better control of both conditions when medically supervised nurses provided guideline-based care.
Note that the nursing-based intervention included visits at primary care clinics every two to three weeks with nurse monitoring of depression, control of medical disease, and self-care activities, along with medication adjustments as More >
Preoperative CTLA-4 Blockade: Tolerability And Immune Monitoring In The Setting Of A Presurgical Clinical Trial
UroToday.com – Intravesical bacillus Calmette-Guerin (BCG) therapy has been approved for decades as the only immunomodulatory agent that treats superficial bladder cancer. We recently reported on the use of a novel immunotherapeutic agent, anti-CTLA-4 antibody, in patients with localized bladder cancer. (1)
Cytotoxic T cell antigen-4 (CTLA-4) is an inhibitory T cell molecule that acts to restrict T cell function, thereby regulating normal More >
DOD awards grant to develop ‘lab-on-a-chip’ device for monitoring patients with severe brain injury
The US Department of Defense (DOD) has awarded a $5 million grant to The Feinstein Institute for Medical Research and the University of Cincinnati to further develop a "lab-on-a-chip" device used for monitoring patients suffering from severe brain injury.
Management of severe brain trauma calls for cutting-edge tools to monitor patients during the critical first few hours and days after an injury. Working through the Feinstein Institute, More >
Data Monitoring Committee Unanimously Recommends Continuation Of Celsion’s Phase III ThermoDox® HEAT Study To Treat Primary Liver Cancer
Celsion Corporation (Nasdaq: CLSN), a leading oncology drug development company, announced that after reviewing data from 401 patients enrolled in its pivotal Phase III ThermoDox ® clinical study (the HEAT study) for primary liver cancer, the Data Monitoring Committee (DMC) has unanimously recommended that the trial continue to enroll patients with the goal of reaching the 600 patients required to complete the study. The Company previously announced More >
Biogen Idec concurs with FDA on safety monitoring for Gilenya through REMS
Biogen Idec is committed to improving the lives of people with multiple sclerosis (MS), and no company is doing more for these patients. There has been a desire within the MS community for an oral treatment for a long time, and the approval of Gilenya has made this a reality.
MS impacts each person differently and, until we have a cure, there should be multiple treatments available to address the individual needs of patients. Today, Biogen More >
Stroke Monitoring Needed for Millions of Americans in Early Stages of Kidney Disease
New research by investigators at Wake Forest University Baptist Medical Center says that millions of Americans in the early stages of chronic kidney disease (CKD) are at an increased risk of having atrial fibrillation (AF) a major risk factor for stroke.
While it is known in the medical community that patients with end-stage renal failure have high rates of AF, new findings show that patients in early stages of CKD experience similar rates of AF, More >
At-Home Blood Pressure Monitoring Helps Keep it Low
British researchers say that people who have High blood pressure can control their condition more effectively on their own at home if they undergo proper training. In a recent study, the scientists found that hypertension patients who used telemonitoring of their blood pressure and adjusted their medications according to guidelines agreed upon in advance saw greater reductions in blood pressure than patients receiving standard care.
Source: http://www.healthcentral.com/heart-disease/news-529594-98.html
Optimal Outcomes with Vascular Endothelial Growth Factor (VEGF) Inhibitors Require Appropriate Hypertension Assessment, Monitoring, and Management
An expert panel provided consensus recommendations for appropriate prevention, surveillance and treatment of hypertension (high blood pressure) in patients treated with vascular endothelial growth factor (VEGF) signaling pathway inhibitors. These recommendations were recently published in the Journal of the National Cancer Institute.[1]
Researchers continue to evaluate novel Therapeutic strategies, such as targeted therapies, for the treatment More >
Embracing the Continuous Glucose Monitoring System
I’ve found that one of most liberating actions is changing your mind. To that end, I’ve decided to give continuous glucose monitoring a try.
Since my recent post outlined the reasoning for avoiding CGMS for the time being, I’m sure most readers will be confused by my sudden change of heart. However, if I’m completely honest, the previous post was written in an attempt to convince myself as much as anyone. I’ve always More >